Concert Medical, a manufacturer interventional medical devices, has launched 'Conductor' family of interventional coronary guidewires in the US market. The guidewires are designed to address an extensive range of coronary disease cases at a superior value.

Concert Medical had received FDA clearance for the use and sale of the Conductor product line in the US in September 2009.

Concert Medical said that the Conductor guidewires offer enhanced trackability and crossability, with an increased reliable strength and superior torque response.

Howard Donnelly, president of Concert Medical, said: “Earlier this year we launched a private-labeled neurological guidewire, co-developed with a leading medical device company. The Conductor, which we spent two years developing, is an outstanding addition to our interventional guidewire business.

“Whether it’s for our own product line or private labeled for a customer, we add a lot of value to the design and manufacturing of medical products. With close to 30 years of experience in the fields of Interventional Cardiology and Interventional Neurology, we have the knowledge, expertise, and resources to bring innovative products and updates to the marketplace.”

Concert Medical, formerly The MicroSpring Company, was founded in 1982 as an exclusively contract manufacturer and was acquired by Mr Donnelly and his partners in 2005. Since the acquisition, Mr Donnelly has moved Concert from a contract manufacturer to a private label and proprietary medical device product developer.